Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Genital Neoplasms, Female × nintedanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Neoplasms 6 Ovarian Neoplasms 3 Uterine Cervical Neoplasms 1 Solid Tumors 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Patients With Any Advanced Solid Tumors 1 Malignant Solid Tumour 1 Leukemia, Myeloid, Acute 1 Genital Neoplasms, Female 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

temsirolimus 1 rucaparib 1 niraparib 1 nintedanib 1 atezolizumab 1 Topotecan 1 Paclitaxel 1 Fulvestrant 1 Cell Count 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02182245 2025-01-23

Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies

Boehringer Ingelheim

Phase 1 Completed

Genital Neoplasms, Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡